Authorized for emergency use by the FDA, the Dimension Vista® SARS‑CoV‑2 IgG (COV2G) assay is a critical tool in detecting IgG antibodies against SARS-CoV-2, aiding in the diagnosis of COVID-19.
Designed for use in laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, capable of performing moderate- or high-complexity tests.
Optimized for the Dimension Vista System, this assay kit includes 240 tests, ensuring reliable and efficient COVID-19 testing capabilities for healthcare facilities.
Storage requirements include refrigeration, safeguarding the integrity and effectiveness of the reagent.
